Svafa Grönfeldt
Director/Miembro de la Junta en EMBLA MEDICAL HF. .
Fortuna: 90 125 $ al 30/04/2024
Perfil
Svafa Grönfeldt is the founder of The MET Fund LLC.
She currently holds the following positions: Vice Chairman at Össur hf since 2008, Director at Marel hf since 2021, Director at Icelandair Group hf since 2019, and Professor at Massachusetts Institute of Technology since 2016.
She previously held positions as Deputy Chief Executive Officer at Actavis Group hf from 2002 to 2007, Director at Landsbankinn hf, Director at Origo hf from 2019 to 2021, Director at Alvogen, Inc. from 2010 to 2011, Managing Partner at Deloitte & Touche LLP, Assistant Professor at the University of Iceland, Member-Supervisory Board at Lotus Pharmaceutical Co., Ltd., and President at Reykjavik University from 2007 to 2010.
Dr. Grönfeldt's education includes a graduate degree from Florida Institute of Technology, Inc. and a doctorate degree from London School of Economics & Political Science.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ICELANDAIR GROUP HF
0.03% | 31/12/2023 | 12 500 000 ( 0.03% ) | 90 125 $ | 30/04/2024 |
Cargos activos de Svafa Grönfeldt
| Empresas | Cargo | Inicio |
|---|---|---|
| EMBLA MEDICAL HF. | Director/Miembro de la Junta | 01/02/2008 |
| ICELANDAIR GROUP HF. | Director/Miembro de la Junta | 08/03/2019 |
| MAREL HF. | Director/Miembro de la Junta | 01/03/2021 |
The MET Fund LLC
 The MET Fund LLC Investment ManagersFinance The MET Fund LLC (MET Fund) is a venture capital firm founded in 2019 by Norbert Chang and Svafa Grönfeldt. The firm is headquartered in Boston. | Fundador | - |
| Massachusetts Institute of Technology | Corporate Officer/Principal | 01/01/2021 |
Antiguos cargos conocidos de Svafa Grönfeldt.
| Empresas | Cargo | Fin |
|---|---|---|
| ORIGO HF. | Director/Miembro de la Junta | 01/01/2021 |
| Reykjavik University | Presidente | 01/01/2010 |
Actavis Group hf
 Actavis Group hf Pharmaceuticals: MajorHealth Technology Actavis Group hf develops, manufactures and sells generic pharmaceuticals. The company was founded in 1957 and is headquartered in Hafnarfjörður, Iceland. | Corporate Officer/Principal | 01/01/2007 |
| LOTUS PHARMACEUTICAL CO., LTD. | Director/Miembro de la Junta | - |
| ░░░░░░░░ ░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formación de Svafa Grönfeldt.
| Florida Institute of Technology, Inc. | Graduate Degree |
| London School of Economics & Political Science | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 5 |
|---|---|
| EMBLA MEDICAL HF. | Health Technology |
| LOTUS PHARMACEUTICAL CO., LTD. | Health Technology |
| ICELANDAIR GROUP HF. | Transportation |
| ORIGO HF. | Distribution Services |
| MAREL HF. | Producer Manufacturing |
| Empresas privadas | 5 |
|---|---|
Landsbankinn hf
 Landsbankinn hf Major BanksFinance Landsbankinn hf engages in the provision of banking and financial services. It operates through the following segments: Personal Banking, Corporate Banking, Markets, Treasury, and Support Functions. The Personal Banking segment provides financial services through the bank’s branch network to individuals and to small and medium-size businesses. The Corporate Banking offers financial services to corporate clients and to small and medium-size businesses. The Markets segment includes brokerage services in securities, foreign currencies and derivatives, securities offerings, and advisory services. The Treasury segment incorporates the bank’s funding and liquidity management, market making in money markets, and determines the bank’s internal pricing. The Support Functions segment consists of finance (excluding treasury), risk management, and information technology; as well as the chief executive officer's office which comprises of human resources, marketing and communications, and compliance. The company was founded in 1886 and is headquartered in Reykjavik, Iceland. | Finance |
Alvogen, Inc.
 Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Alvogen, Inc. develops, manufactures, and distributes generic pharmaceutical products. The firm's business include product development, contract manufacturing and research, sales of generic medicines, bio-similar, and over the counters. Its product portfolio consists of molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology and gastroenterology. The company was founded by Robert Wessman in 2009 and is headquartered in Pine Brook, NJ. | Health Technology |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
The MET Fund LLC
The MET Fund LLC Investment ManagersFinance The MET Fund LLC (MET Fund) is a venture capital firm founded in 2019 by Norbert Chang and Svafa Grönfeldt. The firm is headquartered in Boston. | Finance |
Actavis Group hf
Actavis Group hf Pharmaceuticals: MajorHealth Technology Actavis Group hf develops, manufactures and sells generic pharmaceuticals. The company was founded in 1957 and is headquartered in Hafnarfjörður, Iceland. | Health Technology |
- Bolsa de valores
- Insiders
- Svafa Grönfeldt
